OPB-51822

N/A

Report date: 2022/01/22 15:45:59

Base Information

Drug NameOPB-51822
Drug Alias NameOPB-51822
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSignal transducer and activator of transcription 3 inhibitors
TargetsSignal transducer and activator of transcription 3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesOtsuka Holdings Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOtsuka Holdings Co Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A